This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor:—
In The Journal of the American Medical Association, January 31, page 331, the editorial on "The Papanicolaou Test for Uterine Cancer" concludes with the paragraph:"Recently a manufacturer of laboratory equipment has promoted the sale of the materials for the Papanicolaou test together with a hundred slides of various types of cells found in cervical smears. The firm cannot, however, sell the most important ingredient—a competent pathologist to study the specimen promptly after it is secured from the patient. The offer implies that special training is not necessary to secure and to examine the specimen. The indiscriminate use of this test will result in more harm than good."We wish to take exception to the statement, "the offer implies that special training is not necessary to secure and to examine the specimen." Our advertisement (adv. p. 54) in the Dec. 27, 1947 issue of The Journal very
Davidson E. THE PAPANICOLAOU TEST FOR UTERINE CANCER. JAMA. 1948;136(10):711. doi:10.1001/jama.1948.02890270053022
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: